SKI Market

Indian Indices

Nifty

22,502.00 35.90
(0.16%)

Sensex

74,013.50 7.56
( 0.01%)

Bank Nifty

48,199.50 83.85
( 0.17%)

Nifty IT

33,438.75 56.90
( 0.17%)

Global Indices

Nasdaq

16,794.88 108.91
(0.65%)

Dow Jones

39,806.77 -196.82
(-0.49%)

Hang Seng

19,220.62 -415.60
(-2.12%)

Nikkei 225

38,946.93 -122.75
(-0.31%)

Forex

USD-INR

83.30 -0.18
(-0.21%)

EUR-INR

90.53 -0.23
(-0.25%)

GBP-INR

105.79 -0.01
(-0.01%)

JPY-INR

0.54 0.00
(-0.78%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kimia Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530313

INE285U01025

0.0815159

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

223.6

EPS(TTM)

Face Value()

Div & Yield %

Back

laurel organics ltd

Kimia Biosciences reports standalone net loss of Rs 1.95 crore in the December 2023 quarter

Feb 15,2024

Net Loss of Kimia Biosciences reported to Rs 1.95 crore in the quarter ended December 2023 as against net loss of Rs 3.46 crore during the previous quarter ended December 2022. Sales declined 9.24% to Rs 26.14 crore in the quarter ended December 2023 as against Rs 28.80 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	26.14	28.80	-9
OPM %	-4.02	-10.24	-
PBDT	-1.78	-3.74	52
PBT	-2.60	-4.58	43
NP	-1.95	-3.46	44

22,502.00 35.90 (0.16%)

74,013.50 7.56 ( 0.01%)

48,199.50 83.85 ( 0.17%)

33,438.75 56.90 ( 0.17%)

16,794.88 108.91 (0.65%)

39,806.77 -196.82 (-0.49%)

19,220.62 -415.60 (-2.12%)

38,946.93 -122.75 (-0.31%)

83.30 -0.18 (-0.21%)

90.53 -0.23 (-0.25%)

105.79 -0.01 (-0.01%)

0.54 0.00 (-0.78%)